SYN
Synthetic Biologics, Inc.
AMEXHealthcareBiotechnologyUS
Company Profile
CEO
Steven Shallcross
IPO Date
1993-02-12
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Synthetic Biologics, Inc.
CEO
Steven Shallcross
IPO Date
1993-02-12
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
| 110,000 |
| $0.59 |
| 15 Dec 2023 | Wolf Jeffrey Alan | director | A-Award | Acquired | 110,000 | $0.59 |
| 15 Dec 2023 | SHALLCROSS STEVEN A | director, officer: CEO and CFO | A-Award | Acquired | 700,000 | $0.59 |
| 8 Jun 2023 | SHALLCROSS STEVEN A | director, officer: CEO and CFO | P-Purchase | Acquired | 14,000 | $0.69 |
| 7 Jun 2023 | SHALLCROSS STEVEN A | director, officer: CEO and CFO | P-Purchase | Acquired | 26,000 | $0.63 |
| 13 Feb 2023 | SHALLCROSS STEVEN A | director, officer: CEO and CFO | P-Purchase | Acquired | 25,000 | $1.04 |
| 3 Feb 2023 | SHALLCROSS STEVEN A | director, officer: CEO and CFO | P-Purchase | Acquired | 25,000 | $0.94 |
| 26 Jan 2023 | SHALLCROSS STEVEN A | CEO and CFO | P-Purchase | Acquired | 25,000 | $0.87 |
| 23 Jan 2023 | SHALLCROSS STEVEN A | CEO and CFO | P-Purchase | Acquired | 25,000 | $0.75 |